PFM Health Sciences’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-360,000
Closed -$12.8M 101
2020
Q2
$12.8M Sell
360,000
-87,700
-20% -$2.56M 0.66% 52
2020
Q1
$6.04M Buy
+447,700
New +$7.53M 0.5% 50

PFM Health Sciences's IMMU Position: Q4 2020 in Review

PFM Health Sciences sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,343,570 shares — an estimated $114M sold.

PFM Health Sciences first reported a position in IMMU in Q4 2019 and held it in 4 quarters. The position peaked at $114M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • PFM Health Sciences reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • PFM Health Sciences sold 1,343,570 Immunomedics Inc shares in Q4 2020, an estimated $114M.
  • PFM Health Sciences first reported a position in Immunomedics Inc in Q4 2019 and held it in 4 quarters.
  • PFM Health Sciences's Immunomedics Inc position peaked at $114M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.